NYMOX PHARMACEUTICAL CORPORATION Finance Income Cost
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Finance Income Cost of -$12.00 thousand for the 3-month period ending 2020-09-30, per its 6-K filed 2020-11-13.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:FinanceIncomeCost · last filed 2020-11-13
- NYMOX PHARMACEUTICAL CORPORATION finance income cost for the quarter ending 2020-09-30 was -$12.00K, a 126.67% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION finance income cost for the quarter ending 2019-09-30 was $45.00K.
| Period end | Finance Income Cost 3 month | Finance Income Cost 9 month |
|---|---|---|
| 2020-09-30 | -$12.00K 6-K · filed 2020-11-13 | -$6.00K 6-K · filed 2020-11-13 |
| 2019-09-30 | $45.00K 6-K · filed 2020-11-13 | $143.00K 6-K · filed 2020-11-13 |